Entries for February 2014

Ilan Ganot left his job at JP Morgan to start a new business model that may save his son's life. Hi son, who is 2 years old, was diagnosed with Duchenne muscular dystrophy, a fatal genetic disease a year ago. Ganot has raised $17 million to start a business aimed at getting treatments to market. Read more of this Bloomberg article at:
http://www.bloomberg.com/news/2014-02-20/jpm...

The Parkinson's Institute and Clinical Center and Berg is now focusing on identifying potential biomarkers that may lead to breakthroughs in diagnosis, research, and treatment of Parkinson's disease. To read more from PRNewswire, go to the following link:
http://www.prnewswire.co.uk/news-releases/berg-and-the-parkinsons-institute-and-clinical-center-announce-key-clinical-study-focused-on-ga...

The AMP's goal is to increase the number of new diagnostics and therapies for patients and reduce the time and cost of developing them. The partnership between 10 biopharmaceutical companies and several non-profit organizations aims to change the current model for creating new diagnostics and treatments by jointly identifying and validating promising biological targets of disease. ...

Big drug companies are coming together with the NIH to share science, blood samples and information. The will be working on identifying targets for new drugs for rheumatoid arthritis, lupus, Type 2 diabetes, and Alzheimer's.
to read more of the Wall Street journal article go to:
http://online.wsj.com/news/articles/SB10001424052702303519404579353442155924498?mg=reno64-...